Healthcare Services

Chronic Kidney Disease Market Expanding with Rising Disease Prevalence

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Chronic Kidney Disease Market Progress Between 2026 And 2030?

The chronic kidney disease market has experienced robust expansion in recent years. It is anticipated to grow from $74.87 billion in 2025 to $79.43 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.1%. The growth observed in the historic period stems from the increasing prevalence of diabetes and hypertension, enhanced access to dialysis infrastructure, advancements in kidney function diagnostics, rising awareness of chronic renal disorders, and the expansion of nephrology care services.

The chronic kidney disease market is anticipated to experience robust expansion over the coming years. It is projected to reach $101.87 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.4%. This growth during the forecast period can be attributed to the escalating development of innovative renal treatments, a heightened demand for patient-focused dialysis choices, the broadening scope of digital monitoring for kidney health, an increased emphasis on preparing for transplants, and greater investments in preventive kidney care. Significant trends expected during this period include a stronger focus on early CKD detection, the increasing adoption of medications designed to protect kidney function, a surge in the utilization of home-based dialysis solutions, the expansion of collaborative care approaches, and an intensified effort to impede the progression of the disease.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

What Leading Drivers Are Supporting The Chronic Kidney Disease Market Expansion?

The rising occurrence of kidney conditions is anticipated to fuel expansion in the chronic kidney disease market. Kidney diseases describe various ailments that impair the function and structure of the kidneys. Medications for these conditions are employed to manage blood pressure in patients and reduce protein loss, aiming to prevent the worsening of kidney impairment, address symptoms, and avert complications. For instance, in June 2023, Kidney Research UK, a UK-based, charity dedicated to funding research into kidney disease, stated that by 2033, the number of individuals affected by CKD stages 3–5 is projected to reach around 3.9 million. Consequently, the growing incidence of kidney disease is a primary catalyst for the growth of the chronic kidney disease market.

Which Segment Classifications Are Used In The Chronic Kidney Disease Market Segment Analysis?

The chronic kidney disease market covered in this report is segmented –

1) By Diagnosis: Blood Test, Urine Test, Imaging Test, Kidney Biopsy

2) By Treatment: Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments

3) By Route of Administration: Oral, Intravenous, Subcutaneous

4) By End-User: Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users

Subsegments:

1) By Blood Test: Serum Creatinine Test, Glomerular Filtration Rate (GFR) Test, Blood Urea Nitrogen (BUN) Test, Electrolyte Tests

2) By Urine Test: Urinalysis, 24-hour Urine Collection, Urine Protein Test, Urine Albumin-To-Creatinine Ratio (ACR)

3) By Imaging Test: Ultrasound, CT Scan, MRI, X-Ray

4) By Kidney Biopsy: Percutaneous Kidney Biopsy, Open Kidney Biopsy, Laparoscopic Kidney Biopsy

What Emerging Trends Are Seen In The Chronic Kidney Disease Market?

Major companies operating in the chronic kidney disease market are adopting strategic partnership approaches to assess the safety and efficacy of an improved Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device. Strategic partnerships denote a process where companies utilize each other’s strengths and resources to achieve mutual benefits and success. For instance, in June 2023, AWAK Technologies Pte Ltd., a Singaporean medical technology company, collaborated with Singapore General Hospital Pte Ltd. (SGH), a Singaporean academic health science center and hospital. Through this partnership, they intend to revolutionize the diagnosis, treatment, and management of kidney disease, which includes the development and testing of a wearable and ultra-portable peritoneal dialysis (PD) system, known as AWAK PD, allowing patients with end-stage kidney disease to receive dialysis at home and while mobile.

Which Firms Are Contributing To The Chronic Kidney Disease Market Ecosystem?

Major companies operating in the chronic kidney disease market are Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp

Get The Full Chronic Kidney Disease Market Report:

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

Where Is The Chronic Kidney Disease Market Most Concentrated Geographically?

North America was the largest region in the chronic kidney disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic kidney disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Chronic Kidney Disease Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

Browse Through More Reports Similar to the Global Chronic Kidney Disease Market 2026, By The Business Research Company

Late Stage Chronic Kidney Disease Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/late-stage-chronic-kidney-disease-drugs-global-market-report

Kidney Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Diabetic Kidney Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795